AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹311 Cr | ₹159 Cr | ₹158 Cr | ₹141 Cr | ₹146 Cr |
What is the latest Contingent Liabilities ratio of AUROBINDO PHARMA ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹311 Cr |
Mar2023 | ₹159 Cr |
Mar2022 | ₹158 Cr |
Mar2021 | ₹141 Cr |
Mar2020 | ₹146 Cr |
How is Contingent Liabilities of AUROBINDO PHARMA Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹311 Cr | 96.39 | |
Mar2023 | ₹159 Cr | 0.50 | |
Mar2022 | ₹158 Cr | 12.01 | |
Mar2021 | ₹141 Cr | -3.53 | |
Mar2020 | ₹146 Cr | - |
Compare Contingent Liabilities of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹63,873.5 Cr | -0.9% | -8.1% | -10.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹398,686.0 Cr | 0.8% | -1.3% | 10.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹176,075.0 Cr | 1.5% | 2.3% | 47.2% | Stock Analytics | |
CIPLA | ₹121,023.0 Cr | -0.3% | 0.9% | -3.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,971.0 Cr | -0.1% | 7.2% | 11.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,121.0 Cr | -2.7% | -0.3% | 9.9% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | -0.9% |
-8.1% |
-10.3% |
SENSEX | 0.1% |
1.2% |
6% |
You may also like the below Video Courses